212 related articles for article (PubMed ID: 12404290)
1. Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma.
Ozaki Y; Kontani K; Hanaoka J; Chano T; Teramoto K; Tezuka N; Sawai S; Fujino S; Yoshiki T; Okabe H; Ohkubo I
Cancer; 2002 Nov; 95(9):1954-62. PubMed ID: 12404290
[TBL] [Abstract][Full Text] [Related]
2. Involvement of 90K/Mac-2 binding protein in cancer metastases by increased cellular adhesiveness in lung cancer.
Ozaki Y; Kontani K; Teramoto K; Fujita T; Tezuka N; Sawai S; Maeda T; Watanabe H; Fujino S; Asai T; Ohkubo I
Oncol Rep; 2004 Nov; 12(5):1071-7. PubMed ID: 15492795
[TBL] [Abstract][Full Text] [Related]
3. Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes for use in cancer immunotherapy.
Ozaki Y; Kontani K; Teramoto K; Fujita T; Tezuka N; Sawai S; Watanabe H; Fujino S; Asai T; Ohkubo I
Biochem Biophys Res Commun; 2004 May; 317(4):1089-95. PubMed ID: 15094380
[TBL] [Abstract][Full Text] [Related]
4. Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes in an HLA-A24 restricted manner.
Kontani K; Teramoto K; Ozaki Y; Fujita T; Tezuka N; Sawai S; Watanabe H; Fujino S; Yokomise H; Ohkubo I
Int J Oncol; 2004 Dec; 25(6):1537-42. PubMed ID: 15547688
[TBL] [Abstract][Full Text] [Related]
5. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
6. CABYR is a novel cancer-testis antigen in lung cancer.
Luo C; Xiao X; Liu D; Chen S; Li M; Xu A; Liu J; Gao S; Wu S; He D
Clin Cancer Res; 2007 Feb; 13(4):1288-97. PubMed ID: 17317841
[TBL] [Abstract][Full Text] [Related]
7. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
8. XAGE-1 expression in non-small cell lung cancer and antibody response in patients.
Nakagawa K; Noguchi Y; Uenaka A; Sato S; Okumura H; Tanaka M; Shimono M; Ali Eldib AM; Ono T; Ohara N; Yoshino T; Yamashita K; Tsunoda T; Aoe M; Shimizu N; Nakayama E
Clin Cancer Res; 2005 Aug; 11(15):5496-503. PubMed ID: 16061866
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency mice.
Mizukami M; Hanagiri T; Yasuda M; Kuroda K; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; So T; Takenoyama M; Sugio K; Yasumoto K
Cancer Res; 2007 Sep; 67(17):8351-7. PubMed ID: 17804751
[TBL] [Abstract][Full Text] [Related]
10. Identification of squamous cell carcinoma antigen-derived peptides having the capacity of inducing cancer-reactive CTLs in HLA-A24+ cancer patients.
Homma S; Harada M; Yano H; Ogasawara S; Shichijo S; Matsueda S; Komatsu N; Shomura H; Maeda Y; Sato Y; Todo S; Itoh K
Int J Oncol; 2006 Sep; 29(3):577-87. PubMed ID: 16865273
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N
Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165
[TBL] [Abstract][Full Text] [Related]
12. Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancer.
Watanabe Y; LePage S; Elliott M; Secrist H; Tanaka T; Kawahara M; Matsumura A; Hosoe S; Ogawara M; Okada M; Repasky B; Sleath P; Wang T; Henderson R
Cancer Immun; 2006 Feb; 6():3. PubMed ID: 16468707
[TBL] [Abstract][Full Text] [Related]
13. The 14-3-3 protein as the antigen for lung cancer-associated human monoclonal antibody AE6F4.
Shoji M; Kawamoto S; Setoguchi Y; Mochizuki K; Honjoh T; Kato M; Hashizume S; Hanagiri T; Yoshimatsu T; Nakanishi K
Hum Antibodies Hybridomas; 1994; 5(3-4):123-30. PubMed ID: 7756577
[TBL] [Abstract][Full Text] [Related]
14. ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer.
John T; Caballero OL; Svobodová SJ; Kong A; Chua R; Browning J; Fortunato S; Deb S; Hsu M; Gedye CA; Davis ID; Altorki N; Simpson AJ; Chen YT; Monk M; Cebon JS
Clin Cancer Res; 2008 Jun; 14(11):3291-8. PubMed ID: 18519755
[TBL] [Abstract][Full Text] [Related]
15. A 17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells.
Autiero M; Cammarota G; Friedlein A; Zulauf M; Chiappetta G; Dragone V; Guardiola J
Eur J Immunol; 1995 May; 25(5):1461-4. PubMed ID: 7774651
[TBL] [Abstract][Full Text] [Related]
16. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein.
Coney LR; Tomassetti A; Carayannopoulos L; Frasca V; Kamen BA; Colnaghi MI; Zurawski VR
Cancer Res; 1991 Nov; 51(22):6125-32. PubMed ID: 1840502
[TBL] [Abstract][Full Text] [Related]
17. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93.
Shitara K; Hanai N; Yoshida H
Cancer Res; 1987 Mar; 47(5):1267-72. PubMed ID: 3545444
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy.
Yoshiura K; Nakaoka T; Nishishita T; Sato K; Yamamoto A; Shimada S; Saida T; Kawakami Y; Takahashi TA; Fukuda H; Imajoh-Ohmi S; Oyaizu N; Yamashita N
Clin Cancer Res; 2005 Nov; 11(22):8201-7. PubMed ID: 16299253
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.
Korangy F; Ormandy LA; Bleck JS; Klempnauer J; Wilkens L; Manns MP; Greten TF
Clin Cancer Res; 2004 Jul; 10(13):4332-41. PubMed ID: 15240519
[TBL] [Abstract][Full Text] [Related]
20. The specific immune response to tumor antigen CP1 and its correlation with improved survival in colon cancer patients.
Liu FF; Dong XY; Pang XW; Xing Q; Wang HC; Zhang HG; Li Y; Yin YH; Fant M; Ye YJ; Shen DH; Zhang Y; Wang S; Chen WF
Gastroenterology; 2008 Apr; 134(4):998-1006. PubMed ID: 18395081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
